用过氧化物酶体增殖剂进行预处理可保护小鼠免受某些但并非所有肝毒素的侵害。 - Suppr | 超能文献

Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.

作者信息

Nicholls-Grzemski F A, Burcham P C, Calder I C, Priestly B G

机构信息

Department of Clinical and Experimental Pharmacology, University of Adelaide, Australia.

出版信息

Ann N Y Acad Sci. 1996 Dec 27;804:742-4. doi: 10.1111/j.1749-6632.1996.tb18687.x.

DOI:10.1111/j.1749-6632.1996.tb18687.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.用过氧化物酶体增殖剂进行预处理可保护小鼠免受某些但并非所有肝毒素的侵害。

Ann N Y Acad Sci. 1996 Dec 27;804:742-4. doi: 10.1111/j.1749-6632.1996.tb18687.x.

2

Peroxisome proliferators: species differences in response of primary hepatocyte cultures.过氧化物酶体增殖剂：原代肝细胞培养物反应中的物种差异

Ann N Y Acad Sci. 1996 Dec 27;804:628-35. doi: 10.1111/j.1749-6632.1996.tb18649.x.

3

Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.

Prog Clin Biol Res. 1991;369:77-89.

4

Effect of feeding clofibrate-containing diet on the hepatic NAD+ level in rats.

J Nutr Sci Vitaminol (Tokyo). 1995 Jun;41(3):341-7. doi: 10.3177/jnsv.41.341.

5

Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.肝脏过氧化物酶体增殖：由两种结构上与氯贝丁酯无关的新型化合物诱导产生。

Science. 1975 Nov 21;190(4216):787-9. doi: 10.1126/science.1198095.

6

Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.过氧化物酶体增殖物介导的蛋白质磷酸化：蛋白质激酶的物种特异性刺激及其在过氧化物酶体增殖物诱导的转录激活中的作用。

Ann N Y Acad Sci. 1996 Dec 27;804:413-23. doi: 10.1111/j.1749-6632.1996.tb18632.x.

7

Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice.联合暴露于选定的过氧化物酶体增殖剂对雄性B6C3F1小鼠肝脏酰基辅酶A氧化酶活性的影响。

Hum Exp Toxicol. 1992 Mar;11(2):83-8. doi: 10.1177/096032719201100204.

8

Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.过氧化物酶体增殖剂对酵母染色体内和染色体间重组的影响。

Carcinogenesis. 1990 Jan;11(1):173-6. doi: 10.1093/carcin/11.1.173.

9

32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.体内大鼠肝脏及体外肝细胞中过氧化物酶体增殖剂-DNA加合物形成的32P后标记分析。

Carcinogenesis. 1985 Jun;6(6):933-6. doi: 10.1093/carcin/6.6.933.

10

Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.新型降血脂药物萘酚平诱导肝脏中微体增殖：与氯苯丁酯的比较。

Biochem Biophys Res Commun. 1973 May 15;52(2):537-43. doi: 10.1016/0006-291x(73)90745-6.

引用本文的文献

1

Toxicity of Gold Nanoparticles in Mice due to Nanoparticle/Drug Interaction Induces Acute Kidney Damage.纳米颗粒与药物相互作用导致金纳米颗粒在小鼠体内产生毒性，进而引发急性肾损伤。

Nanoscale Res Lett. 2020 Jul 2;15(1):141. doi: 10.1186/s11671-020-03371-4.

2

Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.烟酰胺腺嘌呤二核苷酸磷酸（NAD(P)H）：醌氧化还原酶1在氯贝丁酯介导的对乙酰氨基酚肝保护中的作用。

Toxicology. 2007 Feb 12;230(2-3):197-206. doi: 10.1016/j.tox.2006.11.052. Epub 2006 Nov 19.